NDC 70573-099

Ryplazim

Plasminogen

Ryplazim is a Intravenous Injection, Powder, Lyophilized, For Solution in the Plasma Derivative category. It is labeled and distributed by Prometic Biotherapeutics, Inc.. The primary component is Plasminogen.

• Product ID: 70573-099_39339cec-7a8a-4a87-829f-3b91f6698782
• NDC: 70573-099
• Product Type: Plasma Derivative
• Proprietary Name: Ryplazim
• Generic Name: Plasminogen
• Dosage Form: Injection, Powder, Lyophilized, For Solution
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2021-06-04
• Marketing Category: BLA /
• Application Number: BLA125659
• Labeler Name: Prometic Biotherapeutics, Inc.
• Substance Name: PLASMINOGEN
• Active Ingredient Strength: 69 mg/1
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 70573-099-02

1 VIAL, GLASS in 1 CARTON (70573-099-02) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS (70573-099-01)

• Marketing Start Date: 2021-06-04
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details